Correction to: Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer.

Jiang, He; Wang, Guotai; Gu, Jingtao; Xiao, Ying; Wang, Pengli; Huang, Xin; Sha, Huanchen; Wang, Zheng; Ma, Qingyong

Jiang, He; Wang, Guotai; Gu, Jingtao; Xiao, Ying; Wang, Pengli; Huang, Xin; Sha, Huanchen; Wang, Zheng; Ma, Qingyong.

Affiliation

Jiang H; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Wang G; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Gu J; Department of Hepatobiliary Surgery, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China.
Xiao Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Wang P; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Huang X; Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, China.
Sha H; Department of General Surgery, Xi'an Central Hospital, Xi'an 710003, China.
Wang Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.
Ma Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710061, China.

Naunyn Schmiedebergs Arch Pharmacol ; 396(7): 1591-1593, 2023 Jul.

Article in En | MEDLINE | ID: mdl-37093252

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google